A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings

@inproceedings{Navarro2011ACA,
  title={A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings},
  author={Ana Navarro and Mar{\'i}a Teresa Linaza Salda{\~n}a and Concepcion Perez and Sandra Torrades and Javier Rejas},
  booktitle={BMC neurology},
  year={2011}
}
BACKGROUND Neuropathic pain (NeP) is a common symptom of a group of a variety of conditions, including diabetic neuropathy, trigeminal neuralgia, or postherpetic neuralgia. Prevalence of NeP has been estimated to range between 5-7.5%, and produces up to 25% of pain clinics consultations. Due to its severity, chronic evolution, and associated co-morbidities, NeP has an important individual and social impact. The objective was to analyze the effect of pregabalin (PGB) on pain alleviation and… CONTINUE READING